top of page
by Artificial Intelligence Expert
i-Biomarker CaDx
Dedicated to Saving Lives
Early cancer diagnosis with 99-100% accuracy
Non-invasive Collection
Simple blood draw samples for easy, patient-friendly testing.
Advanced Analysis
Utilizing cutting-edge biomarker detection and AI-driven data processing, our technology identifies early cancer signals and monitors treatment response. Capable of detecting up to 32 cancers at early stages.
Rapid Results
Receive personalized reports with actionable insights to guide early intervention and treatment.
i-Biomarker™ CaDx stands out with its unique approach, powered by our advanced AI Platform, offers early diagnosis and screening for multiple cancer types with an exceptional accuracy of 99-100%, setting a new benchmark in the field. This test significantly enhances treatment efficacy, boosts patient survival rates, and lowers healthcare costs.
Early detection is a true lifesaver, significantly cutting mortality rates: 20-40% for breast cancer, 33% for colorectal cancer, over 70% for cervical cancer, 20% for lung cancer and 20-30% for prostate cancer.
bottom of page